ARID2 and breast carcinoma: For MPD, frequent mutations in chromatin remodeling genes, such as lysine methyltransferase 2C (KMT2C) and AT-rich interaction domain 2 (ARID2), are well-documented [4], aligning with its strong association with underlying breast carcinoma.